歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Apoptosis > GSK2656157

瀏覽歷史

S80280

GSK2656157

源葉(MedMol) 99%
  • 英文名:
  • GSK2656157
  • 別名:
  • CAS號(hào):
  • 1337532-29-2
  • 分子式:
  • C23H21FN6O
  • 分子量:
  • 416.45
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車(chē)...
源葉(MedMol) S80280-5mg 99% ¥450.00元 8 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80280-10mg 99% ¥693.60元 10 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80280-50mg 99% ¥1462.00元 7 - - - EA 加入購(gòu)物車(chē)
大包裝詢(xún)價(jià)

提交您的電話(huà)號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: GSK2656157 is a selective and ATP-competitive inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) with an IC50 of 0.9 nM.
  • 靶點(diǎn): EIF2AK3 (PERK):0.9 nM (IC50);EIF2AK1 (HRI):460 nM (IC50);BRK:905 nM (IC50);EIF2AK2 (PKR):905 nM (IC50);MEKK3:954 nM (IC50);Aurora B:1259 nM (IC50);KHS:1764 nM (IC50);LCK:2344 nM (IC50);MLK2:2796 nM (IC50);MEKK3:2847 nM (IC50);ALK5:3020 nM (IC50);MLCK2:3039 nM (IC50);EIF2AK4(GCN2):3162 nM (IC50);c-MER:3431 nM (IC50);PI3Kγ:3802 nM (IC50);WNK3:5951 nM (IC50);LRRK2:6918 nM (IC50);ROCK1:7244 nM (IC50);MSK1:8985 nM (IC50);NEK1:9807 nM (IC50);AXL:9808 nM (IC50);JAK2:24547 nM (IC50);Apoptosis;PERK;Autophagy
  • 體內(nèi)研究:
    GSK2656157 (1.5-150 mg/kg, p.o.) results in dose-dependent inhibition of phospho-PERK Thr980, with more than 80% inhibition at 50 and 150 mg/kg. GSK2656157 (50-150 mg/kg, p.o.) results in dose-dependent inhibition of tumor growth in human tumor xenograft models
  • 參考文獻(xiàn):
    1. Atkins C, et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2013 Mar 15;73(6):1993-2002. 2. Krishnamoorthy J, et al. Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications. Cell Cycle. 2014 Mar 1;13(5):801-6. 3. Ando T, et al. GSK2656157, a PERK inhibitor, reduced LPS-induced IL-1β production through inhibiting Caspase 1 activation in macrophage-like J774.1 cells. Immunopharmacol Immunotoxicol. 2016 Aug;38(4):298-302. 4. Zhao Q, et al. Thioredoxin-interacting protein links endoplasmic reticulum stress to inflammatory brain injury and apoptosis after subarachnoid haemorrhage. J Neuroinflammation. 2017 May 11;14(1):104.
  • 溶解性: 1M  HCl  :  100  mg/mL  (240.12  mM;  ultrasonic  and  adjust  pH  to  1  with  HCl)    DMSO  :  8.33  mg/mL  (20.00  mM;  Need  ultrasonic)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.401 ml 12.006 ml 24.012 ml
    5 mM 0.48 ml 2.401 ml 4.802 ml
    10 mM 0.24 ml 1.201 ml 2.401 ml
    50 mM 0.048 ml 0.24 ml 0.48 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷(xiāo)售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷(xiāo)售條款。